Breaking News Instant updates and real-time market news.

BLK

BlackRock

$445.99

-0.2 (-0.04%)

, CX

Cemex

$3.91

-0.06 (-1.51%)

05:55
10/01/19
10/01
05:55
10/01/19
05:55

Global Interdependence Center to hold a conference

Central Banking Series: Monetary & Economic Policies on Both Sides of the Atlantic will be held in Frankfurt, Germany on September 30-October 1.

BLK

BlackRock

$445.99

-0.2 (-0.04%)

CX

Cemex

$3.91

-0.06 (-1.51%)

NTXFY

Natixis

$0.00

(0.00%)

RY

Royal Bank of Canada

$81.20

0.14 (0.17%)

SWDBY

Swedbank

$0.00

(0.00%)

UBS

UBS

$11.32

(0.00%)

  • 01

    Oct

  • 02

    Oct

  • 11

    Oct

  • 18

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 04

    Dec

BLK BlackRock
$445.99

-0.2 (-0.04%)

09/16/19
JEFF
09/16/19
NO CHANGE
Target $537
JEFF
Buy
BlackRock recent selloff brings 'compelling' entry point, says Jefferies
The 6% pullback in shares of BlackRock since the company's Q2 report brings a "compelling" entry point, Jefferies analyst Daniel Fannon tells investors in a research note. Despite a challenging August, iShares flows are tracking flat year-over-year while fixed income and money market trends "remain solid," says Fannon. He sees "several positive secular trends" for BlackRock and keeps a Buy rating on the shares with a $537 price target.
09/17/19
BOFA
09/17/19
NO CHANGE
BOFA
Buy
BlackRock added to US 1 List at BofA/Merrill
09/18/19
MSCO
09/18/19
NO CHANGE
Target $553
MSCO
Overweight
BlackRock's 'extreme' recent underperformance overdone, says Morgan Stanley
Morgan Stanley analyst Michael Cyprys noted that BlackRock (BLK) shares are down 8% in the last 60 days and the stock has underperformed T. Rowe Price (TROW) shares by 14% points over that time, which he views as "extreme" and calls out as the most significant relative underperformance seen over the past 5 years. In the only other two other examples of similar underperformance he can identify, BlackRock shares recovered "a few hundred basis points" in the subsequent days and weeks, noted Cyprys, who views the recent weakness in the stock as a "compelling tactical buying opportunity." The analyst, who thinks the long-term fundamentals and business growth are intact at BlackRock, keeps an Overweight rating on the shares with a $553 price target.
07/09/19
MSCO
07/09/19
NO CHANGE
MSCO
Morgan Stanley sees C-corp conversion announcement coming from Carlyle
Morgan Stanley analyst Michael Cyprys said he recommends owning Carlyle Group (CG) shares into the quarter, as he believes the company will announce plans to convert to a C-corporation along with its upcoming report, "albeit with a delayed effective date" to allow time for the complex underlying tax impact analysis. He thinks a conversion could bring greater clarity and visibility into targets, which could increase long only interest in the stock, Cyprys tells investors. In his broader preview of the earnings season for the Asset Manager group, the analyst noted that he lowered his Q2 EPS estimates by about 4% on average, cutting his estimates for Traditionals by 0.5%, for Alts by 11.5% and for Market Structure companies by 1.6%.
CX Cemex
$3.91

-0.06 (-1.51%)

09/11/19
HSBC
09/11/19
DOWNGRADE
HSBC
Hold
Cemex downgraded to Hold from Buy at HSBC
08/06/19
HSBC
08/06/19
UPGRADE
HSBC
Buy
Cemex upgraded to Buy from Hold at HSBC
08/12/19
08/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. NetEase (NTES) downgraded to Neutral from Buy at Goldman Sachs with analyst Bill Liu citing the company's Q2 revenues miss, mainly on soft online games growth. 2. Occidental Petroleum (OXY) downgraded to In Line from Outperform at Evercore ISI with analyst Doug Terreson saying the company's "pledge" for greater capital discipline and enhanced corporate governance "proved fleeting" with the significant decline in return on capital employed due to the Anadarko acquisition. 3. Adesto Technologies (IOTS) downgraded to Market Perform from Outperform at Northland with analyst Gus Richard saying the company has $34M of high interest debt and needs $10M to pay an earnout by year end, but he thinks the company is holding off on an offering until it reports a "strong" third quarter that will be boosted by an airpod win at Apple (AAPL). 4. Bluebird Bio (BLUE) downgraded to Market Perform from Outperform at William Blair with analyst Raju Prasad saying he's taking a conservative view on the company's transition from a development-stage company to a commercial-stage company. 5. Cemex (CX) downgraded to Market Perform from Outperform at BBVA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/12/19
BBVA
08/12/19
DOWNGRADE
Target $3.6
BBVA
Market Perform
Cemex downgraded to Market Perform from Outperform at BBVA
BBVA analyst Francisco Martinez downgraded Cemex to Market Perform from Outperform and lowered his price target for the shares to $3.60 from $7.30.
NTXFY Natixis
$0.00

(0.00%)

07/11/19
GSCO
07/11/19
UPGRADE
GSCO
Buy
Natixis upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Jean-Francois Neuez upgraded Natixis to Buy from Neutral with a price target of 5.40 euros. The analyst views the shares as attractively priced following the recent drop.
06/27/19
UBSW
06/27/19
UPGRADE
UBSW
Buy
Natixis upgraded to Buy from Neutral at UBS
UBS analyst Lorraine Quoirez upgraded Natixis to Buy from Neutral while lowering her price target for the shares to EUR 3.90 from EUR 4.80. The analyst believes the recent selloff in the shares prices in an extreme scenario which is unlikely to occur.
06/21/19
HSBC
06/21/19
DOWNGRADE
HSBC
Hold
Natixis downgraded to Hold from Buy at HSBC
HSBC analyst Kiri Vijayarajah downgraded Natixis to Hold from Buy and lowered his price target for the shares to 4 euros from 6 euros.
04/03/19
BOFA
04/03/19
INITIATION
BOFA
Neutral
Natixis reinstated with a Neutral at BofA/Merrill
BofA/Merrill reinstated coverage of Natixis with an Neutral rating. The firm has a cautious view on French banks saying the need to build up capital will take many years and that 2020 targets are "uninspiring."
RY Royal Bank of Canada
$81.20

0.14 (0.17%)

11/29/18
ARGS
11/29/18
NO CHANGE
Target $89
ARGS
Buy
Royal Bank of Canada price target lowered to $89 from $94 at Argus
Argus analyst Stephen Biggar lowered his price target on Royal Bank of Canada to $89 after its Q1 earnings, saying the revision is mostly driven by the less favorable currency rate. The analyst also keeps his Buy rating on the bank based on its "leading positions in personal/commercial banking, capital markets, and wealth management", anticipating the company's earnings growth to outpace that of other Canadian banks. With a dividend yield over 4%, Biggar is also positive on Royal Bank of Canada's "income story", noting that its slight valuation premium is justified by its earnings growth, efficiency, and profitability metrics.
12/12/18
MACQ
12/12/18
UPGRADE
MACQ
Outperform
Royal Bank of Canada upgraded to Outperform from Neutral at Macquarie
12/10/18
TDSI
12/10/18
UPGRADE
TDSI
Buy
Royal Bank of Canada upgraded to Buy from Hold at TD Securities
12/10/18
12/10/18
UPGRADE

Buy
Royal Bank of Canada upgraded to Buy on domestic strength at TD Securities
As previously reported, TD Securities upgraded Royal Bank of Canada to Buy from Hold with a C$115 price target. Analyst Richard Roth prefers Royal Bank's domestic market strength and diversity of its business model in periods of market uncertainty and consistent superior earnings growth.
SWDBY Swedbank
$0.00

(0.00%)

09/23/19
MSCO
09/23/19
UPGRADE
MSCO
Overweight
Swedbank upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Bruce Hamilton upgraded Swedbank to Overweight from Equal Weight.
02/27/19
KBWI
02/27/19
DOWNGRADE
KBWI
Market Perform
Swedbank downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Richard Smith downgraded Swedbank to Market Perform and lowered his price target for the shares to 200 kronor from 245 kronor.
05/17/19
LEHM
05/17/19
DOWNGRADE
LEHM
Equal Weight
Swedbank downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Paulina Sokolova downgraded Swedbank to Equal Weight from Overweight and lowered her price target for the shares to 159 kronor from 245 kronor.
07/17/19
JPMS
07/17/19
DOWNGRADE
JPMS
Underweight
Swedbank downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Sofie Peterzens downgraded Swedbank to Underweight from Neutral with a price target of 130 kronor, down from 180 kronor.
UBS UBS
$11.32

(0.00%)

09/10/19
KPLR
09/10/19
UPGRADE
KPLR
Buy
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
08/30/19
DOWNGRADE

Fly Intel: Top analyst downgrade
Catch up on today's top analyst downgrades with this list compiled by The Fly: 1. Ulta Beauty (ULTA) downgraded to Neutral from Buy at Citi, to Neutral from Overweight at Piper Jaffray and Atlantic Equities, to Neutral from Outperform at Exane BNP Paribas, to Market Perform from Outperform at Wells Fargo, and to Equal Weight from Overweight at Morgan Stanley. 2. Toronto-Dominion (TD) downgraded to Market Perform from Outperform at BMO Capital with analyst Sohrab Movahedi saying he views the company's Q4 results as a "low-quality meet" and believes the stock's total return potential is now in line with other similarly rated banks. 3. Novo Nordisk (NVO) downgraded to Underperform from Hold at Jefferies with analyst Peter Welford saying he believes the shares at current levels are becoming expensive. 4. UBS (UBS) downgraded to Neutral from Outperform at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/30/19
EXAN
08/30/19
DOWNGRADE
EXAN
Neutral
UBS downgraded to Neutral from Outperform at Exane BNP Paribas
Exane BNP Paribas analyst Jeremy Sigee downgraded UBS to Neutral from Outperform and lowered his price target for the shares to 11.40 francs from 14.20 francs.
08/21/19
DZBN
08/21/19
DOWNGRADE
DZBN
Sell
UBS downgraded to Sell from Hold at DZ Bank

TODAY'S FREE FLY STORIES

CPST

Capstone Turbine

$2.60

0.005 (0.19%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Capstone Turbine announces 1 MW project in Colombia with Ecopetrol »

Capstone Turbine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$16.79

0.23 (1.39%)

08:40
11/18/19
11/18
08:40
11/18/19
08:40
Hot Stocks
Embraer says Air Peace signs firm order for three additional E195-E2 jets »

Embraer announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$130.73

5.62 (4.49%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

AMRN

Amarin

$23.99

2.5 (11.63%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Conference/Events
Amarin to host conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

CYDY

CytoDyn

$0.00

(0.00%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Hot Stocks
CytoDyn engages LifeSci Public Relations as communications partner »

CytoDyn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$23.39

0.31 (1.34%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Downgrade
Health Insurance Innovations rating change  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMBI

iMedia Brands

$0.64

0.0001 (0.02%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Hot Stocks
iMedia Brands to launch Bulldog shopping network on November 22 »

iMedia Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

ESTC

Elastic

$74.06

1.94 (2.69%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Upgrade
Elastic rating change  »

Elastic upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

AON

Aon plc

$198.67

0.01 (0.01%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Downgrade
Aon plc rating change  »

Aon plc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$259.91

6.14 (2.42%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Hot Stocks
ServiceNow appoints Gina Mastantuono as CFO, says CEO has assumed role »

ServiceNow announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

CTL

CenturyLink

$14.98

0.09 (0.60%)

, INFN

Infinera

$6.70

0.34 (5.35%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Hot Stocks
CenturyLink, Infinera bring terabit capacity to supercomputing network »

CenturyLink (CTL) and…

CTL

CenturyLink

$14.98

0.09 (0.60%)

INFN

Infinera

$6.70

0.34 (5.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

CPA

Copa Holdings

$106.77

-1.94 (-1.78%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Recommendations
Copa Holdings analyst commentary  »

Copa Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

MMC

Marsh & McLennan

$105.50

0.16 (0.15%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Upgrade
Marsh & McLennan rating change  »

Marsh & McLennan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Hot Stocks
Breaking Hot Stocks news story on T-Mobile »

T-Mobile down 1.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Earnings
T-Mobile appoints Mike Sievert as CEO effective May 1 »

T-Mobile announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

RCAR

RenovaCare

$0.00

(0.00%)

, EMIS

Emisphere Tech

$0.00

(0.00%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Hot Stocks
RenovaCare appoints Alan Rubino as president, CEO »

RenovaCare (RCAR)…

RCAR

RenovaCare

$0.00

(0.00%)

EMIS

Emisphere Tech

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTFT

Future FinTech

$0.61

-0.067 (-9.97%)

08:34
11/18/19
11/18
08:34
11/18/19
08:34
Hot Stocks
Future FinTech announces agreement with Chifeng Supply and Marketing Company »

Future FinTech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.18

0.075 (6.82%)

08:34
11/18/19
11/18
08:34
11/18/19
08:34
Recommendations
J.C. Penney analyst commentary  »

Deutsche Bank stays on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$25.48

-1.2 (-4.50%)

08:33
11/18/19
11/18
08:33
11/18/19
08:33
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRI

Herc Holdings

$50.03

0.2 (0.40%)

08:33
11/18/19
11/18
08:33
11/18/19
08:33
Hot Stocks
Herc Holdings appoints Wade Sheek as chief legal officer »

Herc Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WY

Weyerhaeuser

$29.35

0.03 (0.10%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Recommendations
Weyerhaeuser analyst commentary  »

Weyerhaeuser price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLV

Enlivex Therapeutics

$8.45

0.15 (1.81%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Enlivex Therapeutics completes recruitment in Phase Ib trial of Allocetra »

Enlivex Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Breaking Hot Stocks news story on T-Mobile »

T-Mobile appoints Mike…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

AMRS

Amyris

$3.85

-0.03 (-0.77%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Amyris moves into regulatory stage with new health and nutrition molecule »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TSLA

Tesla

$352.22

2.71 (0.78%)

08:31
11/18/19
11/18
08:31
11/18/19
08:31
Recommendations
Tesla analyst commentary  »

Tesla price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.